Harnessing hematological ratios: prognostic insights for breast cancer management.

Autor: Coradi C; Laboratory of Tumor Biology, Centro de Ciências da Saúde, Universidade Estadual do Oeste do Paraná, Rodovia Vitório Traiano, Km2, Francisco Beltrão, Paraná, Brazil., Panis C; Laboratory of Tumor Biology, Centro de Ciências da Saúde, Universidade Estadual do Oeste do Paraná, Rodovia Vitório Traiano, Km2, Francisco Beltrão, Paraná, Brazil. carolpanis@hotmail.com.
Jazyk: angličtina
Zdroj: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Oct 14. Date of Electronic Publication: 2024 Oct 14.
DOI: 10.1007/s12094-024-03721-z
Abstrakt: Background: Breast cancer is one of the most lethal diseases affecting women globally. Its progression is influenced by various factors, including the immune system's ability to combat cancer cells. While hematological indices have been recognized as valuable biomarkers for monitoring patients with different types of neoplasms, there remains a considerable gap in research concerning their application in breast cancer.
Material and Methods: To address this, we conducted a systematic review of studies examining hematological indices as prognostic predictors in breast cancer patients.
Results: The majority of studies demonstrate a significant correlation between these indices and survival outcomes, underscoring their potential utility in patient monitoring.
Conclusions: Hematological-based indexes can be valuable tools for monitoring breast cancer, especially those ongoing poor prognosis scenarios.
(© 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).)
Databáze: MEDLINE
Externí odkaz: